ZA879211B - Medicament form for urapidil - Google Patents

Medicament form for urapidil

Info

Publication number
ZA879211B
ZA879211B ZA879211A ZA879211A ZA879211B ZA 879211 B ZA879211 B ZA 879211B ZA 879211 A ZA879211 A ZA 879211A ZA 879211 A ZA879211 A ZA 879211A ZA 879211 B ZA879211 B ZA 879211B
Authority
ZA
South Africa
Prior art keywords
urapidil
medicament form
medicament
Prior art date
Application number
ZA879211A
Other languages
English (en)
Inventor
Benedikt Gerald
Dietrich Rango
Original Assignee
Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung filed Critical Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung
Publication of ZA879211B publication Critical patent/ZA879211B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA879211A 1986-12-09 1987-12-08 Medicament form for urapidil ZA879211B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH489486 1986-12-09

Publications (1)

Publication Number Publication Date
ZA879211B true ZA879211B (en) 1988-06-09

Family

ID=4284381

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879211A ZA879211B (en) 1986-12-09 1987-12-08 Medicament form for urapidil

Country Status (12)

Country Link
EP (1) EP0275444A1 (pt)
JP (1) JPS63162623A (pt)
KR (1) KR880007066A (pt)
CN (1) CN87107534A (pt)
AU (1) AU8222787A (pt)
DK (1) DK639787A (pt)
FI (1) FI875372A (pt)
HU (1) HUT45896A (pt)
IL (1) IL84599A0 (pt)
NO (1) NO875121L (pt)
PT (1) PT86323B (pt)
ZA (1) ZA879211B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1232161B (it) * 1989-07-31 1992-01-25 Sigma Tau Ind Farmaceuti Uso dell'acido sebacico e di suoi derivati nell'alimentazione enterale e parentaerale e composizioni farmaceutiche contenenti tali composti
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition

Also Published As

Publication number Publication date
DK639787A (da) 1988-06-10
CN87107534A (zh) 1988-07-13
NO875121L (no) 1988-06-10
FI875372A0 (fi) 1987-12-07
PT86323A (de) 1988-01-01
JPS63162623A (ja) 1988-07-06
EP0275444A1 (de) 1988-07-27
HUT45896A (en) 1988-09-28
FI875372A (fi) 1988-06-10
KR880007066A (ko) 1988-08-26
DK639787D0 (da) 1987-12-04
PT86323B (pt) 1990-11-07
AU8222787A (en) 1988-06-09
NO875121D0 (no) 1987-12-08
IL84599A0 (en) 1988-04-29

Similar Documents

Publication Publication Date Title
EP0265797A3 (en) Synchrotron
GB8619432D0 (en) Pharmaceutical compounds
ZA877699B (en) Pharmaceutical combination
GB8607178D0 (en) Dosage means
GB8628475D0 (en) Medicaments
GB8521395D0 (en) Medicament
GB8708225D0 (en) Dosage form
ZA879211B (en) Medicament form for urapidil
GB8625326D0 (en) Medicaments
EP0305902A3 (en) Medicament
EP0272929A3 (en) Enkephalinase for therapeutic use
GB8521342D0 (en) Medicament
IE873206L (en) Drug form for urapidil
GB8605695D0 (en) Inhalers
BG43026A1 (en) Lyposomic pharmaceutical form
GB8511255D0 (en) Medicament preparation
GB8602260D0 (en) Medicaments
GB8630072D0 (en) Medicaments
GB8630081D0 (en) Medicaments
GB8630077D0 (en) Medicaments
GB8630078D0 (en) Medicaments
GB8630082D0 (en) Medicaments
GB8630083D0 (en) Medicaments
GB8630903D0 (en) Medicaments
GB8630074D0 (en) Medicaments